由内向外技术用于胸段中心静脉阻塞安全有效
单中心研究纳入2007年8月至2021年5月221例患者共338次由内向外技术操作,用于透析通路、药物输注、心脏通路等适应证,技术安全有效且可重复进行;更复杂的SIR TCVO分型与更长透视时间和更多造影剂相关,装置耐久性主要受感染并发症限制。
要点
- 由内向外技术可用于多种适应证建立中心静脉通路,无操作相关并发症。
- SIR TCVO 3型和4型较1型和2型透视时间更长、造影剂用量更多。
- 装置中位使用时长76.5天,装置移除主要原因为感染(42.1%)。
核心结论
- 由内向外技术对胸段中心静脉阻塞患者建立中心静脉通路安全有效且可重复进行。
- 更复杂的阻塞模式与更长透视时间和更多造影剂使用相关,耐久性主要受感染并发症限制。
研究设计与样本
- 单中心三级学术中心研究,纳入2007年8月至2021年5月接受由内向外技术行中心静脉通路的患者221例,共338次操作。
- 收集患者人口学、手术指征、操作细节、SIR TCVO分型、结局及操作相关并发症,统计分析采用方差分析。
主要发现
- 221例患者中男性109例(49.3%)、女性112例(50.6%),平均年龄54.7±14.8岁,49例多次接受操作(2次25例、3次11例、>3次13例)。
- 操作指征(n=362)包括透析通路230例次(63.5%)、肠外营养/抗生素/化疗或其他药物输注81例次(22.3%)、心脏通路39例次(10.8%)、其他12例次(3.3%),20次操作有多个指征。
- SIR TCVO分型:1型147次(43.5%)、4型142次(42.0%)、2型36次(10.7%)、3型6次(1.8%)、无法确定7次(2.0%)。
- 3型和4型较1型和2型透视时间更长且造影剂用量更多;中位随访56.0天,装置中位使用时长76.5天,不同SIR TCVO分型间装置使用时长无差异。
- 166例患者记录导管移除,原因包括感染性原因70例(42.1%)、导管功能障碍34例(20.5%)、新建血液透析通路19例(11.5%)、不再需要19例(11.5%)、患者自行拔除13例(7.8%)、临时导管更换为隧道式装置11例(6.6%);无操作相关并发症。
临床怎么用
- 作者结论为由内向外技术对胸段中心静脉阻塞患者建立中心静脉通路安全有效且可重复进行,更复杂阻塞模式与更长透视时间和更多造影剂相关,耐久性主要受感染并发症限制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thoracic central venous obstruction (TCVO) presents a challenging scenario for patients requiring central venous access. The inside-out technique for crossing occluded veins has been described; however, to date, case series have reported on a limited number of patients. The purpose of the present study was to evaluate the indications for, efficacy of, and outcomes with the inside-out technique at a single tertiary academic center, with close attention to the severity of TCVO using the Society of Interventional Radiology (SIR) TCVO classification. METHODS: Patients who had undergone central venous access using the inside-out technique were identified from August 2007 to May 2021. The patient demographics, procedure indication, procedural details, SIR TCVO classification, outcomes, and procedure-related complications were recorded. Statistical analysis was performed using analysis of variance. RESULTS: A total of 221 patients (109 men [49.3%] and 112 women [50.6%]) had undergone 338 inside-out procedures. Of the 221 patients, 49 had undergone the procedure multiple times (25 two times, 11 three times, 13 more than three times). The average patient age was 54.7 ± 14.8 years. The indications (n = 362) for the procedure included dialysis access (n = 230; 63.5%), infusion of parenteral nutrition, antibiotics, chemotherapy, or other medication (n = 81; 22.3%), cardiac access (n = 39; 10.8%), and other (n = 12; 3.3%); more than one indication for 20 procedures. Type 1 SIR TCVO was found during 147 procedures (43.5%), followed by type 4 for 142 (42.0%), type 2 for 36 (10.7%), type 3 for 6 (1.8%), and unable to determine for 7 (2.0%). The access site was the right femoral vein for 322 procedures (95.3%), left femoral vein for 14 (4.1%), and transhepatically for 2 (0.6%). The exit site location was the right supraclavicular region for 274 (81.3%), right subclavicular for 52 (15.4%), left supraclavicular for 3 (0.9%), left subclavicular for 6 (1.8%), and not defined for 2 (0.6%). Types 3 and 4 were associated with longer fluoroscopy times and more contrast compared with types 1 and 2. The median follow-up and device duration was 56.0 days and 76.5 days, respectively. No differences were found in device duration between the SIR TCVO types. Removal of a catheter was documented for 166 patients. The indications for removal included infectious causes (non-catheter-related bacteremia, catheter-related infection or bacteremia) for 70 (42.1%), catheter malfunction for 34 (20.5%), new hemodialysis access for 19 (11.5%), no longer needed for 19 (11.5%), patient removal of the catheter by 13 (7.8%), and replacement of a temporary catheter with a tunneled device for 11 (6.6%). No procedural complications were associated with the inside-out technique or catheter removal. CONCLUSIONS: For a variety of indications, we have shown that the inside-out technique is safe and effective for establishing central venous access in patients with TCVO and can be performed repeatedly. More complex obstructive patterns were associated with longer fluoroscopy times and greater contrast administration. Durability was primarily limited by infectious complications.
引用
- Aru RG, Chishti EA, Alagusundaramoorthy SS, et al. The inside-out technique is safe and effective for thoracic central venous obstruction. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 35561973. doi:10.1016/j.jvsv.2022.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。